Better Medicine, a startup developing AI-powered diagnostic tools for radiology, has raised 1 million EUR in a pre-seed funding round led by Soulmates Ventures, with participation from Specialist VC, UT Ventures, and several angel investors. The round gained momentum after a 2.5 million EUR grant aw
Subcontract machining firm Kirkstall Precision, Leeds, has enhanced its capability to serve the medical sector with the installation of a Brother SPEEDIO M200Xd1-5AX, a Japanese-built, simultaneous 5-axis CNC machining centre supplied by sole UK and Ireland sales and service agent, Whitehouse Machin
Danish MedTech company VentriJect, a start-up behind a technology that accurately measures cardiorespiratory fitness (CRF) has just closed a 1.7 million EUR funding round following expansion into several European markets. VentriJect is a spinout from Aalborg University in Denmark, and after being
SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, has announced that it has raised 140 million USD in private financing, that will support commercialisation of the SetPoint System, a first-of-its-kind neuroimmune modulation therapy for
GN, a global leader in hearing technology, has announced the launch of ReSound Enzo IA, which the company claims is the world’s smallest rechargeable hearing aid. GN says the ReSound Enzo IA represents a huge leap forward in sound quality for people with severe to profound hearing loss. Understandin
FUCHS Lubricants Co., one of the world’s largest independent lubricant suppliers, has announced the launch of NYEMED 7312, a ‘groundbreaking’ damping grease engineered specifically for the medical device industry. Developed in response to the growing demand for more sustainable materials according t
Apreo Health, a clinical-stage medical device company developing a novel treatment for severe emphysema, has announced the closing of an oversubscribed 130 million USD Series B financing round. The financing was co-led by new investors Bain Capital Life Sciences and Norwest, with participation from
CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, has announced that the 100th patient has received treatment for communicating hydrocephalus with the eShunt System. The 100 patients were enrolled in pilot studies and in the STRIDE clinic
Cardiosense, a medical AI company transforming cardiovascular disease management has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the CardioTag device, the first multimodal, wearable sensor that simultaneously captures high-fidelity electrocardiogram (E
Glasgow-based company CardioPrecision has successfully executed the first clinical cases of robotic aortic valve replacement through a tiny incision in the neck. Last year, the global leader in transcervical access for the treatment of structural heart disease demonstrated a proof-of-concept AVATAR
Sanome, a company building Clinical Decision Support tools to detect emerging health risks, has secured Class IIb CE certification and MHRA approval for MEMORI – an AI-enabled warning system for the early prediction/prevention of healthcare‑associated infections (HAIs) – at the same time as appointi
Cartherics, a biotechnology company developing off-the-shelf immune stem cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian cancer and endometriosis, has unveiled its new cleanroom facility for clinical-scale manufacturing of cell therapy products. The facility wa
